The Gene Therapy stream features two back-to-back conferences focusing on the critical challenges facing the analysis, characterization, quality control and manufacture of viral vector-based gene therapies. Topics include product and process characterization, analytics and quality profiling, comparability, process development, scale-up and commercial manufacturing.

Conferences Include:

Keynote Speakers:

Mark Galbraith, PhD, Head, Quality Control and Analytical Sciences, Spark Therapeutics

Andrew W. Harmon, PhD, Biologist, CMC Reviewer, Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies, FDA CDER

James Warren, PhD, Vice President, Pharmaceutical Development, Ultragenyx Pharmaceutical